Association Between the COVID-19 Pandemic and Insurance-Based Disparities in Mortality After Major Surgery Among US Adults.
Association Between the COVID-19 Pandemic and Insurance-Based Disparities in Mortality After Major Surgery Among US Adults.
复制标题
DOI:
10.1001/jamanetworkopen.2022.22360
复制
发表时间:
2022-07-01
影响因子:
13.8
通讯作者:
Maddox, Karen E. Joynt
中科院分区:
文献类型:
--
作者:
Glance, Laurent G.;Dick, Andrew W.;Shippey, Ernie;McCormick, Patrick J.;Dutton, Richard;Stone, Patricia W.;Shang, Jingjing;Lustik, Stewart J.;Lander, Heather L.;Gosev, Igor;Maddox, Karen E. Joynt
Was the COVID-19 pandemic associated with greater changes in mortality after major surgery among patients with Medicaid insurance or without insurance compared with patients with commercial insurance? In this cross-sectional study of 2 950 147 adults undergoing major surgery, mortality rates among patients with Medicaid insurance and patients without insurance did not increase more than the rate among patients with commercial insurance in hospitals with a high COVID-19 burden compared with hospitals with a low COVID-19 burden. These findings suggest that the early phase of the pandemic was not associated with increases in insurance-based disparities in mortality after major surgery. This cross-sectional study examines whether insurance type was associated with COVID-19 mortality after major surgery among US patients. The COVID-19 pandemic caused significant disruptions in surgical care. Whether these disruptions disproportionately impacted economically disadvantaged individuals is unknown. To evaluate the association between the COVID-19 pandemic and mortality after major surgery among patients with Medicaid insurance or without insurance compared with patients with commercial insurance. This cross-sectional study used data from the Vizient Clinical Database for patients who underwent major surgery at hospitals in the US between January 1, 2018, and May 31, 2020. The hospital proportion of patients with COVID-19 during the first wave of COVID-19 cases between March 1 and May 31, 2020, stratified as low (≤5.0%), medium (5.1%-10.0%), high (10.1%-25.0%), and very high (>25.0%). The main outcome was inpatient mortality. The association between mortality after surgery and payer status as a function of the proportion of hospitalized patients with COVID-19 was evaluated with a quasi-experimental triple-difference approach using logistic regression. Among 2 950 147 adults undergoing inpatient surgery (1 550 752 female [52.6%]) at 677 hospitals, the primary payer was Medicare (1 427 791 [48.4%]), followed by commercial insurance (1 000 068 [33.9%]), Medicaid (321 600 [10.9%]), other payer (140 959 [4.8%]), and no insurance (59 729 [2.0%]). Mortality rates increased more for patients undergoing surgery during the first wave of the pandemic in hospitals with a high COVID-19 burden (adjusted odds ratio [AOR], 1.13; 95% CI, 1.03-1.24; P = .01) and a very high COVID-19 burden (AOR, 1.38; 95% CI, 1.24-1.53; P < .001) compared with patients in hospitals with a low COVID-19 burden. Overall, patients with Medicaid had 29% higher odds of death (AOR, 1.29; 95% CI, 1.22-1.36; P < .001) and patients without insurance had 75% higher odds of death (AOR, 1.75; 95% CI, 1.55-1.98; P < .001) compared with patients with commercial insurance. However, mortality rates for surgical patients with Medicaid insurance (AOR, 1.03; 95% CI, 0.82-1.30; P = .79) or without insurance (AOR, 0.85; 95% CI, 0.47-1.54; P = .60) did not increase more than for patients with commercial insurance in hospitals with a high COVID-19 burden compared with hospitals with a low COVID-19 burden. These findings were similar in hospitals with very high COVID-19 burdens. In this cross-sectional study, the first wave of the COVID-19 pandemic was associated with a higher risk of mortality after surgery in hospitals with more than 25.0% of patients with COVID-19. However, the pandemic was not associated with greater increases in mortality among patients with no insurance or patients with Medicaid compared with patients with commercial insurance in hospitals with a very high COVID-19 burden.
登录
查看更多内容
影响因子:
9
作者:
LaPar DJ;Bhamidipati CM;Mery CM;Stukenborg GJ;Jones DR;Schirmer BD;Kron IL;Ailawadi G
通讯作者:
Ailawadi G
影响因子:
--
作者:
Rosen, Heather;Saleh, Fady;Gawande, Atul A.
通讯作者:
Gawande, Atul A.
影响因子:
158.5
作者:
Baker, DW;Sudano, JJ;Dor, A
通讯作者:
Dor, A
影响因子:
13.8
作者:
Mattingly AS;Rose L;Eddington HS;Trickey AW;Cullen MR;Morris AM;Wren SM
通讯作者:
Wren SM
DOI:
10.1016/j.jss.2021.05.028
发表时间:
2021-11
期刊:
The Journal of surgical research
影响因子:
--
作者:
Prasad NK;Englum BR;Turner DJ;Lake R;Siddiqui T;Mayorga-Carlin M;Sorkin JD;Lal BK
通讯作者:
Lal BK